Amended and Restated Annex A to License Agreement between Villani, Inc. and Dermata Therapeutics, LLC

Contract Categories: Intellectual Property › License Agreements
Summary

This document is an updated annex to a license agreement between Villani, Inc. and Dermata Therapeutics, LLC. It replaces the previous Annex A and lists the specific patents and patent applications related to porifera-based therapeutic compositions for treating and preventing skin diseases. The annex details the countries, application numbers, filing dates, patent numbers, grant dates, and status of each patent. Both parties have signed to confirm the updated list of licensed patent rights as of November 23, 2018.

Read More Arrow
EX-10.10 7 d137089dex1010.htm EX-10.10 EX-10.10

Exhibit 10.10

AMENDED AND RESTATED ANNEX A TO THE LICENSE AGREEMENT

THIS ANNEX (this “Annex”) A is attached to THE LICENSE AGREEMENT dated March 31, 2017 by and between Villani, Inc., a Delaware corporation with mailing address of 220 Newport Center Dr., Suite 11-578, Newport Beach, CA 92660 (the “Licensor”) and Dermata Therapeutics, LLC., a Delaware limited liability company having a principal place of business at 12340 El Camino Real, Suite 425, San Diego, California, 92130 (“Dermata”) as of this 23nd day of November 2018. This Annex replaces and supersedes the Annex A attached to the License Agreement on March 31, 2017.

Annex A

Patent Rights

 

  •  

“Porifera-Based Therapeutic Compositions for Treating and Preventing Skin Diseases”

 

        Country         

   

Application No.

   

Filing Date

   

Patent No.

   

Grant Date

   

Status

United States    10/659,451    09/09/2003    7,604,821    10/20/2009    Granted
Australia    2003278775    09/09/2003    2003278775    10/14/2010    Granted
Brazil    P103184986    09/09/2003    P103184986    07/05/2016    Granted
Canada    2538093    09/09/2003    2538093    06/02/2015    Granted
Europe    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
Switzerland    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
Germany    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
Spain    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
France    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
Great Britain    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
Italy    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
Ireland    EP03770295.8    09/09/2003    EP1663104    02/12/2014    Granted
Japan    2005-509509    09/09/2003    4889093    12/22/2011    Granted
South Korea    10 ###-###-####    09/09/2003    1183075    09/10/2012    Granted
Mexico    PA/a/2006/002744    09/09/2003    277072    06/05/2010    Granted
Singapore    200601545-7    09/09/2003    120379    04/30/2008    Granted
Russia    2006111482    09/09/2003    2345782    02/10/2009    Granted

 

  •  

“Porifera-Based Therapeutic Compositions for Treating and Preventing Skin Diseases”

 

United States    12/543,843    08/19/2003    8,383,100    02/26/2013    Granted

 

  •  

“Porifera-Based Therapeutic Compositions for Treating and Preventing Skin Diseases”

 

United States    14/553,694    11/25/2014                                             Pending

IN WITNESS WHEREOF, the parties hereto have executed this Annex as of the Effective Date.

 

VILLANI, INC     DERMATA THERAPEUTICS, LLC
By: /s/ Maria Villani         By: /s/ Gerald T. Proehl
Maria Villani     Name: Gerald T. Proehl
Chief Executive Officer     Title: President, CEO and Director